Derivatives and analogs of galanthamine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S216000, C540S581000

Reexamination Certificate

active

09980025

ABSTRACT:
New compounds of general formula I

REFERENCES:
patent: 3947445 (1976-03-01), Henry et al.
patent: 5153193 (1992-10-01), Flanagan et al.
patent: 5336675 (1994-08-01), Snorrason
patent: 5428159 (1995-06-01), Shieh et al.
patent: 6043359 (2000-03-01), Czollner et al.
patent: 6369238 (2002-04-01), Czollner et al.
patent: 6407229 (2002-06-01), Czollner et al.
patent: 6638925 (2003-10-01), Czollner et al.
patent: 2004/0067974 (2004-04-01), Czollner et al.
patent: 401 058 (1996-06-01), None
patent: 0 345 808 (1989-12-01), None
patent: 0 236 684 (1992-05-01), None
patent: 0 648 771 (1995-04-01), None
patent: 0 653 427 (1995-05-01), None
patent: 8800350 (1989-09-01), None
patent: 88/08708 (1988-11-01), None
patent: WO 95/27715 (1995-10-01), None
patent: WO 96/12692 (1996-05-01), None
patent: 97/11078 (1997-03-01), None
patent: WO 97/40049 (1997-10-01), None
patent: WO 00/32199 (2000-06-01), None
patent: WO 2005/030333 (2005-04-01), None
Pokorna, L et al ‘Capillary zone electrophoresis determination of galanthamine in biological fluids and pharmaceutical preparatives: Experimental design and artificial neural network optimization’ Electrophoresis 199, 20, 1993-1997.
Poschalko, A et al ‘Synthesis of (+)-6H-benzofuro[3a,3,2,ef][3]benazepine: an unnatural analog of (-)galanthamine’ Tetrahedron 58 (2002) 1513-1518.
Pilger,C et al ‘Accurate prediction of the bound conformation of galanthamine in the active site of Torpedo californica acetylcholinesterase using molecular docking’J. Molecular Graphics and Modelling 19, 288-296, 2001.
Coyle, Galanthamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease, Society of Biological Pysychiatry, (2001), 49:289-299.
Sramek, Review of the acetylcholinesterase inhibitor galanthamine, Exp. Opin. Invest. Drugs (2000) 9(10), 2393-2402.
R. Roques et al., “Structure of Norgalanthamine Hydrochloride”,Acta Crystallogr, Sect. B (1980), vol. B36, No. 7, pp. 1589-1593 XP001009771.
Jaume Bastida et al., “Narcissus Alkaloids. Part 19, Alkaloids from Narcissus Leonensis”,Phytochemistry, (1993), vol. 34, No. 6, pp. 1656-1658, XP001009775.
P. Remuzon, “Fluoronaphthyridines as Antibacterial Agents”,J. Med. Chem., 1992, vol. 35, pp. 2898-2909.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Derivatives and analogs of galanthamine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Derivatives and analogs of galanthamine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives and analogs of galanthamine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3738637

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.